A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials.

Source:http://linkedlifedata.com/resource/pubmed/id/9798753

Download in:

View as

General Info

PMID
9798753